###begin article-title 0
pRb Inactivation in Mammary Cells Reveals Common Mechanisms for Tumor Initiation and Progression in Divergent Epithelia
###end article-title 0
###begin article-title 1
A New Breast Cancer Model
###end article-title 1
###begin p 2
###xml 122 123 122 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 348 349 348 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 767 768 767 768 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 781 782 781 782 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 800 803 800 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 867 868 867 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 1060 1063 1060 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1129 1132 1129 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1181 1184 1181 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1223 1226 1223 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1363 1366 1363 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 311 316 <span type="species:ncbi:9606">human</span>
###xml 704 709 <span type="species:ncbi:10090">mouse</span>
###xml 819 823 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1146 1150 <span type="species:ncbi:10090">mice</span>
###xml 1641 1646 <span type="species:ncbi:9606">human</span>
Retinoblastoma 1 (pRb) and the related pocket proteins, retinoblastoma-like 1 (p107) and retinoblastoma-like 2 (p130) (pRbf, collectively), play a pivotal role in regulating eukaryotic cell cycle progression, apoptosis, and terminal differentiation. While aberrations in the pRb-signaling pathway are common in human cancers, the consequence of pRbf loss in the mammary gland has not been directly assayed in vivo. We reported previously that inactivating these critical cell cycle regulators in divergent cell types, either brain epithelium or astrocytes, abrogates the cell cycle restriction point, leading to increased cell proliferation and apoptosis, and predisposing to cancer. Here we report that mouse mammary epithelium is similar in its requirements for pRbf function; Rbf inactivation by T121, a fragment of SV40 T antigen that binds to and inactivates pRbf proteins, increases proliferation and apoptosis. Mammary adenocarcinomas form within 16 mo. Most apoptosis is regulated by p53, which has no impact on proliferation, and heterozygosity for a p53 null allele significantly shortens tumor latency. Most tumors in p53 heterozygous mice undergo loss of the wild-type p53 allele. We show that the mechanism of p53 loss of heterozygosity is not simply the consequence of Chromosome 11 aneuploidy and further that chromosomal instability subsequent to p53 loss is minimal. The mechanisms for pRb and p53 tumor suppression in the epithelia of two distinct tissues, mammary gland and brain, are indistinguishable. Further, this study has produced a highly penetrant breast cancer model based on aberrations commonly observed in the human disease.
###end p 2
###begin p 3
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
Inactivation of the three retinoblastoma genes in the mouse mammary gland provides a new animal model for human breast cancer
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 129 134 129 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 248 261 248 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Marshall1">Marshall 1991</xref>
###xml 263 276 263 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Weinberg1">Weinberg 1995</xref>
###xml 278 288 278 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Sherr1">Sherr 1996</xref>
###xml 290 308 290 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Ortega1">Ortega et al. 2002</xref>
###xml 770 785 770 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Luo1">Luo et al. 1998</xref>
###xml 787 814 787 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Robanus-Maandag1">Robanus-Maandag et al. 1998</xref>
###xml 816 838 816 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Dannenberg1">Dannenberg et al. 2000</xref>
###xml 840 856 840 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Sage1">Sage et al. 2000</xref>
###xml 893 895 893 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 940 958 940 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Marino1">Marino et al. 2000</xref>
###xml 1029 1048 1029 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Maandag1">Maandag et al. 1994</xref>
###xml 1050 1070 1050 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Williams1">Williams et al. 1994</xref>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 763 768 <span type="species:ncbi:10090">mouse</span>
###xml 993 997 <span type="species:ncbi:10090">mice</span>
Aberrant retinoblastoma 1 (pRb) pathway activity, resulting from defects in pRb itself, cyclin-dependent kinase inhibitor 2A (p16INK4a), cyclin D1 (CCND1), or cyclin-dependent kinase 4 (CDK4), is observed in the majority of human sporadic cancers (Marshall 1991; Weinberg 1995; Sherr 1996; Ortega et al. 2002). This pathway is commonly altered early in cancer development, indicating an ability to predispose cells to tumorigenesis. However, whether the mechanism(s) is similar among cell types is not known. Examination of pRb inactivation in specific cell types in vivo has been technically challenging due to the apparent functional compensation or redundancy among pRb, retinoblastoma-like 1 (p107), and retinoblastoma-like 2 (p130) in many cell types of the mouse (Luo et al. 1998; Robanus-Maandag et al. 1998; Dannenberg et al. 2000; Sage et al. 2000). Thus, genetic inactivation of the Rb gene alone, either by conditional deletion (Marino et al. 2000) or by the generation of chimeric mice harboring pRb-deficient cells (Maandag et al. 1994; Williams et al. 1994) yields only medulloblastomas, pituitary, and thyroid tumors.
###end p 5
###begin p 6
###xml 86 87 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 165 168 165 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 275 295 275 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-DeCaprio1">DeCaprio et al. 1989</xref>
###xml 297 314 297 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Dyson2">Dyson et al. 1989</xref>
###xml 316 332 316 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Ewen1">Ewen et al. 1989</xref>
###xml 334 353 334 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Stubdal1">Stubdal et al. 1997</xref>
###xml 355 375 355 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Sullivan1">Sullivan et al. 2000</xref>
###xml 132 137 <span type="species:ncbi:10090">mouse</span>
###xml 193 208 <span type="species:ncbi:10633">simian virus 40</span>
###xml 210 214 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
We have begun to systematically examine the role of retinoblastoma protein family (pRbf) inactivation in multiple cell types of the mouse by dominant expression of T121, a truncation mutant of simian virus 40 (SV40) T antigen that inactivates all three pRb-related proteins (DeCaprio et al. 1989; Dyson et al. 1989; Ewen et al. 1989; Stubdal et al. 1997; Sullivan et al. 2000). In this report we determine the role of pRb inactivation in mammary adenocarcinoma predisposition, establish a role for p53 inactivation in subsequent mammary adenocarcinoma progression, and, together with our previous studies, provide a comprehensive comparison of these mechanisms in distinct epithelial lineages.
###end p 6
###begin p 7
###xml 196 220 196 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Sherr2">Sherr and McCormick 2002</xref>
###xml 418 435 418 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Hamel1">Hamel et al. 1992</xref>
###xml 437 458 437 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Weintraub1">Weintraub et al. 1992</xref>
###xml 593 610 593 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Brehm1">Brehm et al. 1998</xref>
###xml 612 627 612 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Luo1">Luo et al. 1998</xref>
###xml 629 656 629 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Magnaghi-Jaulin1">Magnaghi-Jaulin et al. 1998</xref>
###xml 765 786 765 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Morris1">Morris and Dyson 2001</xref>
###xml 1100 1110 1100 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Dyson1">Dyson 1998</xref>
pRb plays a critical role in eukaryotic cell cycle progression, when cells exit G0 or G1 and enter S phase, thereby acting as a crucial negative regulator of cellular proliferation and neoplasia (Sherr and McCormick 2002). In quiescent or early G1-phase cells, pRb is hypophosphorylated and associates with specific members of the E2F transcription factor family, converting them to active transcriptional repressors (Hamel et al. 1992; Weintraub et al. 1992). Gene repression is also mediated by pRb and p130 recruitment of histone deacetylase to promote formation of inhibitory nucleosomes (Brehm et al. 1998; Luo et al. 1998; Magnaghi-Jaulin et al. 1998). The many proteins found in association with pRb suggest other regulatory mechanisms may also be involved (Morris and Dyson 2001), although the biological potential for most of these interactions remains yet unproven. Cell cycle progression from G to S phase occurs when complexes of D-type cyclins/CDK4/CDK6 phosphorylate pRb, thereby derepressing E2Fs to direct transcription of DNA-replication machinery and nucleotide biosynthesis genes (Dyson 1998).
###end p 7
###begin p 8
###xml 132 151 132 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Buckley1">Buckley et al. 1993</xref>
###xml 157 162 157 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4A</sup>
###xml 176 199 176 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Geradts1">Geradts and Wilson 1996</xref>
###xml 239 262 239 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Geradts1">Geradts and Wilson 1996</xref>
###xml 272 274 272 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 599 618 599 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Maandag1">Maandag et al. 1994</xref>
###xml 634 637 634 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 631 637 631 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pRb<sup>&#8722;/&#8722;</sup></italic>
###xml 795 815 795 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Robinson1">Robinson et al. 2001</xref>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 285 290 <span type="species:ncbi:10090">mouse</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
Like most human solid tumors, breast cancers harbor frequent alterations in the pRb pathway, including CCND1 overexpression in 45% (Buckley et al. 1993), p16INK4A loss in 49% (Geradts and Wilson 1996), and pRb loss in 6% of breast tumors (Geradts and Wilson 1996). In the Rb-deficient mouse mammary gland, p107 and/or p130 may play overlapping or compensatory roles, as they do during embryonic development, given that pRb is dispensable for normal mammary development and mammary tumor suppression. pRb-deficient embryonic stem cells participate in normal mammary gland formation in chimeric mice (Maandag et al. 1994), and donor pRb-/- mammary precursor cells transplanted into wild-type mice can populate a normal mammary gland without evidence of neoplasia, even after multiple pregnancies (Robinson et al. 2001).
###end p 8
###begin p 9
###xml 207 210 207 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 310 327 310 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Nigro1">Nigro et al. 1989</xref>
###xml 329 351 329 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Greenblatt1">Greenblatt et al. 1994</xref>
###xml 581 582 581 582 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 685 704 685 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Symonds3">Symonds et al. 1994</xref>
###xml 757 758 757 758 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 879 883 879 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 966 982 966 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Xiao1">Xiao et al. 2002</xref>
###xml 186 191 <span type="species:ncbi:9606">human</span>
The interplay between pRb signaling and the tumor protein p53 pathway is also critical to the understanding of breast cancer biology. Since the pRb pathway is defective in a majority of human tumors and the p53 gene is mutated in about half of them, including approximately a fifth of sporadic breast cancers (Nigro et al. 1989; Greenblatt et al. 1994), these aberrations often coexist. Whether loss of these tumor suppressor pathways collaborate in tumorigenesis is also cell type-specific. In a brain epithelial tumor model, we previously demonstrated that, in the absence of pRbf function, inactivation of p53 significantly decreases apoptosis and accelerates tumor growth in vivo (Symonds et al. 1994). However, in astrocytic brain tumors induced by pRbf inactivation, tumor progression is not accelerated by reduced p53 activity; rather, the phosphatase and tensin homolog (PTEN) regulates the apoptosis, and reduction in its function accelerates tumor growth (Xiao et al. 2002).
###end p 9
###begin p 10
###xml 97 98 97 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
In this report, we extend our analysis of pRb function in vivo and examine the consequence of pRbf loss specifically in mammary epithelium. These studies serve not only to provide insight into the cell specificity of tumor suppression mechanisms, but also to model the stepwise evolution of breast adenocarcinomas that harbor defects in this pathway.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 14 18 <span type="species:ncbi:10090">Mice</span>
Generation of Mice with Inducible pRbf Deficiency in Mammary Cells
###end title 12
###begin p 13
###xml 48 51 48 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T<sub>121</sub></italic>
###xml 129 137 129 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g001">Figure 1</xref>
###xml 143 164 143 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 323 331 323 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g002">Figure 2</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
Seven founder mice were generated in which the T121 gene was regulated by the whey acidic protein (WAP) transcriptional signals (Figure 1; see Materials and Methods). Of these, two founder animals died spontaneously of unknown causes, while the transgenic progeny of the third line died prematurely, also of unknown cause (Figure 2A). The extent to which the transgene contributed to these deaths was not investigated further; however, ectopic transgene expression was detected in several tissues (data not shown). Characterization of female mice of the four remaining lines is the focus of this report.
###end p 13
###begin title 14
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
T121 Is Expressed in Lactating Mammary
###end title 14
###begin p 15
###xml 99 102 99 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 151 159 151 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g002">Figure 2</xref>
###xml 164 167 164 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 337 340 337 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 357 365 357 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g002">Figure 2</xref>
###xml 622 625 622 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 707 715 707 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g002">Figure 2</xref>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
Western immunoblotting analyses of mammary gland extracts demonstrated that this tissue expresses T121 protein at the expected size in all four lines (Figure 2B). T121 expression in lines 1 and 2 was only revealed following immunoprecipitation using an anti-T-antigen antibody prior to Western blot analysis, indicating lower levels of T121 (right panel in Figure 2B). A survey of select tissues showed that detectable expression was restricted to the mammary gland in lines 1-3, while expression was more widespread in the higher expressing line 4 (data not shown) and included brain and kidney expression. As expected, T121 expression was induced by lactation with highest levels observed 5 d postpartum (Figure 2C). Southern blot analyses indicate that mice in line 3, which was used as a representative line for extensive characterization, harbor approximately ten copies of the transgene at a single insertion site (data not shown).
###end p 15
###begin title 16
###xml 12 14 12 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f </sub>
Impact of Rbf Inactivation in Mammary Epithelium
###end title 16
###begin p 17
###xml 127 128 127 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 144 145 144 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 177 179 177 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 448 456 448 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">Figure 3</xref>
###xml 510 518 510 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">Figure 3</xref>
###xml 571 579 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">Figure 3</xref>
###xml 584 587 584 587 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 658 666 658 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">Figure 3</xref>
###xml 669 670 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">3</xref>
###xml 677 678 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">3</xref>
###xml 694 695 694 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 719 722 719 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 803 811 803 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">Figure 3</xref>
###xml 824 827 824 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 922 930 922 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">Figure 3</xref>
###xml 1072 1080 1072 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">Figure 3</xref>
###xml 1083 1084 1083 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">3</xref>
###xml 1091 1092 1091 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">3</xref>
###xml 1170 1178 1170 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">Figure 3</xref>
###xml 1181 1182 1181 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">3</xref>
###xml 1189 1190 1189 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">3</xref>
###xml 1213 1216 1213 1216 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 1289 1297 1289 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g002">Figure 2</xref>
###xml 1354 1362 1354 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g004">Figure 4</xref>
###xml 1426 1429 1426 1429 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 1552 1555 1552 1555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 1599 1602 1599 1602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
Representative histological analysis of lactating mammary glands (day 1) from single-pregnancy females of the line 2 founder (F0) and a line 3 F1 mouse shows that the impact of Rb perturbation is severalfold. Compared to an age- and parity-matched control tissue, the normal architecture of the lactating mammary tissue is disturbed. In contrast to normal tissue where acini consist of a single layer of secretory epithelia with milk-filled lumen (Figure 3A), transgenic animals have a lower density of acini (Figure 3K), consistent with atrophy, and are often atypical (Figure 3I). T121-positive mammary epithelial cells were associated with abnormalities (Figure 3B, 3F, and 3J). The line 2 F0 animal was mosaic for T121 protein expression with distinct regions of expressing and nonexpressing cells (Figure 3F), whereas T121 expression in the line 3 animal was in secretory epithelium distributed throughout the gland (Figure 3J). Increased proliferation, indicated by proliferating cell nuclear antigen (PCNA) staining, was also observed in transgenic mammary glands (Figure 3C, 3G, and 3K), concomitant with increased levels of apoptosis assayed by TUNEL staining (Figure 3D, 3H, and 3L). Quantification of T121 expression and apoptosis revealed higher protein expression levels (see Figure 2B) correlate with higher percentages of apoptotic cells (Figure 4A). Consistent with a model for cell-autonomous functioning of T121, the pattern of abnormalities of morphology, proliferation, and apoptosis in the mosaic animal mimicked the regionalized T121 expression pattern, and conversely, where T121 protein was absent, the tissue appeared normal.
###end p 17
###begin title 18
Role of p53 in Apoptosis
###end title 18
###begin p 19
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 205 208 205 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 433 436 433 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 445 453 445 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g004">Figure 4</xref>
###xml 612 615 612 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 656 659 656 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 692 695 692 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 714 722 714 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g004">Figure 4</xref>
###xml 824 827 824 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 896 899 896 899 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 972 975 972 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1016 1030 1016 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Lu1">Lu et al. 2001</xref>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
To investigate the impact of germline loss of p53 on apoptosis levels in Rbf-deficient mammary glands, we mated line 3 animals to p53 null mice to generate transgenic and nontransgenic females of distinct p53 genotypes (+/+, +/-, -/-). Transgene expression was induced by a single pregnancy, and mammary glands were examined on lactation day 1. As expected, nontransgenic mammary glands showed no appreciable apoptosis regardless of p53 status (Figure 4B). However, in transgenic animals, decreased levels of p53 activity were correlated with lower levels of apoptosis. The mean percentage of apoptotic cells in p53 wild-type transgenic glands was 21%; in p53 heterozygous animals, 9%;and in p53 null animals, 5% (Figure 4B), indicating that 75% of the apoptosis is p53-dependent. That we could detect haploinsufficiency of p53 for apoptosis is remarkable, since in the previously characterized T121-expressing choroid plexus epithelium, apoptosis levels were the same in p53 heterozygous and wild-type backgrounds (Lu et al. 2001). This observation indicates that there is a threshold for p53 levels in eliciting apoptosis and that either the threshold is different between cell types or that the absolute functional p53 level is distinct. Such differences could have significant impact on the requirements for tumorigenesis.
###end p 19
###begin title 20
Role of p53 in Proliferation
###end title 20
###begin p 21
###xml 140 147 140 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Ha-ras</italic>
###xml 150 169 150 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Hundley1">Hundley et al. 1997</xref>
###xml 174 182 174 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wingless</italic>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt-1</italic>
###xml 253 274 253 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Donehower1">Donehower et al. 1995</xref>
###xml 524 525 524 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 678 681 678 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 685 690 685 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt-1</italic>
###xml 692 695 692 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 790 798 790 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g004">Figure 4</xref>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 103 106 <span type="species:ncbi:10116">rat</span>
###xml 191 197 <span type="species:ncbi:10090">murine</span>
###xml 219 223 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
In two other transgenic mouse models of breast cancer, where tumors were initiated by activated Harvey rat sarcoma viral oncogene homolog (v-Ha-ras) (Hundley et al. 1997) or wingless-related murine mammary tumor virus (MMTV) integration site 1 (Wnt-1) (Donehower et al. 1995), inactivation of p53 did not result in a reduction of apoptosis; rather, loss of p53 was associated with increased proliferation of the mammary epithelium. To determine whether p53 inactivation also impacted mammary cell proliferation induced by Rbf inactivation, glands from primiparous lactating (day 1) mice were assessed for the expression of nuclear PCNA. Unlike the tumors initiated by activated Ras or Wnt-1, p53 heterozygosity or nullizygosity had no significant impact on the level of cell proliferation (Figure 4C). This experiment indicates that p53 can have distinct mechanisms of action depending on the nature of the initiating lesion.
###end p 21
###begin title 22
pRb Inactivation Predisposes to Tumorigenesis
###end title 22
###begin p 23
###xml 195 198 195 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 432 440 432 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g005">Figure 5</xref>
###xml 509 530 509 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 572 573 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 584 592 584 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g005">Figure 5</xref>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
All females from higher-expressing lines (lines 3 and 4) failed to nurse pups because of lactation defects and developed mammary tumors after multiple pregnancies. Because line 4 mice expressed T121 in nonmammary tissues, further characterization focused on line 3. For this line, the median time following initial transgene induction until a palpable tumor appeared was 10 mo, and within 16 mo, all mice developed palpable tumors (Figure 5A). Interestingly, latency in this line on a BALB/cJ background (see Materials and Methods) was reduced to a median time of 8.5 mo (p = 0.0077; Figure 5A) indicating the presence of modifier alleles. The condensed timeframe for tumor development in this strain will also be valuable for future preclinical studies using this model. However, all further studies in the current report were carried out on the original B6D2F1 background.
###end p 23
###begin p 24
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 193 197 193 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121 </sub>
###xml 188 197 188 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121 </sub></italic>
###xml 217 220 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 274 277 274 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 271 277 271 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/+</sup></italic>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 297 300 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 294 300 294 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 302 303 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 392 395 392 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 887 888 887 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 902 903 902 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 319 324 <span type="species:ncbi:10090">mouse</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
The median onset for mammary tumors in line 4 was 14 mo (n = 3; data not shown), which indicates that the transgene and not its insertion caused tumorigenesis. With two exceptions, line 3 WAP-T121 mice, regardless of p53 status, developed a single palpable tumor (87% of p53+/+, n = 15; 78% of p53+/-, n = 9). A single mouse with either two or three palpable tumors was also observed in both p53 +/+ and +/- backgrounds. At least one additional nonpalpable tumor was visible during necropsy in approximately one-third of all tumor-bearing mice. While the two lower-expressing lines, lines 1 and 2, were able to nurse pups and appeared grossly normal, both had hyperplastic lobular alveoli associated with increased levels of proliferation and apoptosis. However, females from low-expressing lines did not develop adenocarcinomas after at least four pregnancies and 20 mo of age (line 1, n = 2; line 2, n = 6) (data not shown).
###end p 24
###begin p 25
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 91 99 91 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g006">Figure 6</xref>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g006">6</xref>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g006">6</xref>
###xml 160 168 160 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g006">Figure 6</xref>
###xml 174 175 174 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g006">6</xref>
###xml 210 218 210 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g006">Figure 6</xref>
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g006">6</xref>
###xml 503 511 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g006">Figure 6</xref>
###xml 684 692 684 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g006">Figure 6</xref>
###xml 1146 1154 1146 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g006">Figure 6</xref>
###xml 348 354 <span type="species:ncbi:9606">humans</span>
Most terminal stage tumors in either wild-type or p53+/- backgrounds were adenocarcinomas (Figure 6A, 6B, and 6E); however, we also observed four pilar tumors (Figure 6C and 6E) and one spindle cell carcinoma (Figure 6D and 6E). Terminal-stage mammary adenocarcinomas resembled poorly to moderately differentiated invasive ductal adenocarcinoma in humans. Morphologically, we designate these tumors as mixed solid and glandular carcinomas with necrosis and fibrosis. Poorly differentiated solid tumors (Figure 6A) are composed of nests of epithelial cells with large pleomorphic nuclei and delicate chromatin patterns with inverted nuclear:cytoplasmic ratios, while glandular tumors (Figure 6B) are composed of irregular glands with varying degrees of differentiation. While most animals had a single tumor mass, the adenocarcinomas were multifocal, with solid tumors consisting of subclones of distinct expansile masses, and with only two exceptions, glandular tumors were coincident with solid tumors. The adenocarcinomas were malignant, infiltrating dense, fibrous connective tissue, and were accompanied by strong peripheral immune response (Figure 6A).
###end p 25
###begin title 26
Mammary Tumor Onset and Growth Are Accelerated by p53 Reduction
###end title 26
###begin p 27
###xml 40 41 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 71 74 71 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 230 233 230 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 310 313 310 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 307 313 307 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 321 324 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 318 324 318 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 432 449 432 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Jacks1">Jacks et al. 1994</xref>
###xml 451 471 451 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Sandgren1">Sandgren et al. 1995</xref>
###xml 473 495 473 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Dannenberg1">Dannenberg et al. 2000</xref>
###xml 505 508 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 502 508 502 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 515 516 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 672 675 672 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 669 675 669 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 741 749 741 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g005">Figure 5</xref>
###xml 752 753 752 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 781 784 781 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 778 784 778 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/+</sup></italic>
###xml 824 827 824 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 831 834 831 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 819 834 819 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub>;p53<sup>+/&#8722;</sup></italic>
###xml 877 880 877 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 909 917 909 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g005">Figure 5</xref>
###xml 964 967 964 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 961 967 961 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/+</sup></italic>
###xml 991 994 991 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 988 994 988 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 1082 1083 1082 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1233 1236 1233 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
Since 75% of the apoptosis induced by Rbf inactivation was mediated by p53 and was indeed reduced even in p53+/- mice, we investigated the impact of p53 loss on tumor onset and growth kinetics. Animals harboring either one or two p53 null alleles were monitored for mammary tumors. As expected, a subset of p53+/- and p53-/- mice developed nonmammary tumors (either thymic lymphomas or sarcomas), consistent with published reports (Jacks et al. 1994; Sandgren et al. 1995; Dannenberg et al. 2000). All p53-/- mice (n = 4) succumbed to these tumors by 4 mo of age, prior to developing palpable mammary tumors, so acceleration of this phenotype could not be assessed. In p53+/- animals, mammary tumors were detected significantly earlier (see Figure 5A; p = 0.0003) compared with p53+/+ mice. Furthermore, once palpable, WAP-T121;p53+/- tumors grew significantly faster than the p53 wild-type counterparts (see Figure 5B). The observation of four pilar tumors in p53+/+ animals and none in p53+/- animals is a statistically significant difference (Fisher-Freeman-Halton's exact test, p = 0.0177) and suggests that the reduction of p53 activity drives tumors to the adenocarcinoma phenotype. Taken together, these studies indicate that p53 heterozygosity leads to increased tumor growth rates and/or progression and may alter the spectrum of tumor morphologies.
###end p 27
###begin title 28
Selective Pressure for p53 Inactivation during Adenocarcinoma Development
###end title 28
###begin p 29
###xml 50 53 50 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 45 60 45 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub>;p53<sup>+/&#8722;</sup></italic>
###xml 103 106 103 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 110 113 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 98 113 98 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub>;p53<sup>+/+</sup></italic>
###xml 141 144 141 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 399 402 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 418 421 418 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 425 428 425 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 413 428 413 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub>;p53<sup>+/&#8722;</sup></italic>
###xml 487 490 487 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 499 506 499 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0020022-t001">Table 1</xref>
###xml 566 569 566 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 573 576 573 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 561 576 561 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub>;p53<sup>+/&#8722;</sup></italic>
###xml 814 817 814 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1056 1064 1056 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g004">Figure 4</xref>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Since apoptosis was significantly reduced in WAP-T121;p53+/- mammary tissue compared with that of WAP-T121;p53+/+ mice, it was possible that p53 heterozygosity was sufficient for tumor acceleration. To assess whether this was the case or whether there was selective pressure for p53 inactivation during tumor progression, real-time PCR analysis was employed to determine the status of the wild-type p53 allele in WAP-T121;p53+/- tumors. Of ten tumors, eight showed loss of the wild-type p53 allele (Table 1), indicating that the apoptosis reduction observed in WAP-T121;p53+/-mammary epithelium was not sufficient for tumor progression. Significant selective pressure favored cells that had completely inactivated p53, indicating that tumor progression requires further reduction of apoptotic activity and/or that p53 loss contributes to tumor progression through additional mechanisms that confer selective advantage. Assessment of apoptosis levels in terminal tumors showed apoptosis levels were indeed reduced in comparison to preneoplastic tissue (see Figure 4B).
###end p 29
###begin title 30
Comparative Genomic Hybridization Reveals Recurrent Chromosomal Imbalances in Tumors, but Limited Chromosomal Instability
###end title 30
###begin p 31
###xml 317 320 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 309 320 309 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt-1p53<sup>+/&#8722;</sup></italic>
###xml 322 343 322 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Donehower1">Donehower et al. 1995</xref>
###xml 361 364 361 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 349 364 349 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-ras p53<sup>+/&#8722;</sup></italic>
###xml 366 385 366 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Hundley1">Hundley et al. 1997</xref>
###xml 394 397 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 391 397 391 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 429 454 429 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Venkatachalam1">Venkatachalam et al. 1998</xref>
###xml 673 687 673 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Lu1">Lu et al. 2001</xref>
###xml 881 884 881 884 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 888 891 888 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 876 891 876 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub>;p53<sup>+/&#8722;</sup></italic>
###xml 1008 1016 1008 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g007">Figure 7</xref>
###xml 1019 1042 1019 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Kallioniemi1">Kallioniemi et al. 1992</xref>
###xml 1083 1091 1083 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g007">Figure 7</xref>
###xml 1094 1119 1094 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Solinas-Toldo1">Solinas-Toldo et al. 1997</xref>
###xml 1121 1139 1121 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Pinkel1">Pinkel et al. 1998</xref>
###xml 160 165 <span type="species:ncbi:10090">mouse</span>
###xml 349 353 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Among the multiple mechanisms of tumor suppression attributed to p53, a common hypothesis is that p53 prevents genetic instability. Indeed, studies using other mouse models indicate loss of p53 function in tumors often correlates with chromosomal instability. These include other breast cancer models such as Wnt-1p53+/- (Donehower et al. 1995) and MMTV-ras p53+/- (Hundley et al. 1997) and p53+/- thymic lymphomas and sarcomas (Venkatachalam et al. 1998). In marked contrast, our study of p53 deficiency in an evolving brain epithelial tumor showed that tumorigenesis progresses without chromosomal instability, indicating p53 loss contributes via alternative mechanisms (Lu et al. 2001). To determine whether this difference was due to cell-type specificity, differences in initiating mechanisms, or differences in experimental approaches, we analyzed the genome of mammary WAP-T121;p53+/- tumors. We employed two methods of comparative genomic hybridization (CGH): chromosome-based CGH (cCGH) (Panel I in Figure 7) (Kallioniemi et al. 1992) and microarray CGH (aCGH) (Panel II in Figure 7) (Solinas-Toldo et al. 1997; Pinkel et al. 1998).
###end p 31
###begin p 32
###xml 148 156 148 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g007">Figure 7</xref>
###xml 227 230 227 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1315 1319 1315 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-myc</italic>
###xml 1351 1369 1351 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Weaver1">Weaver et al. 1999</xref>
###xml 1389 1405 1389 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Ried1">Ried et al. 1995</xref>
###xml 1469 1474 1469 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1521 1527 1521 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">erb-b2</italic>
###xml 1583 1586 1583 1586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neu</italic>
###xml 1610 1630 1610 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Montagna1">Montagna et al. 2002</xref>
###xml 1632 1650 1632 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Weaver2">Weaver et al. 2002</xref>
###xml 1329 1334 <span type="species:ncbi:10090">mouse</span>
###xml 1375 1380 <span type="species:ncbi:9606">human</span>
###xml 1486 1491 <span type="species:ncbi:10090">mouse</span>
Twelve mammary tumors were assayed by CGH: ten by cCGH, eight by aCGH, and six by both procedures. Both assays revealed limited genomic imbalances (Figure 7), yet only a single tumor showed loss of Chromosome 11 (which harbors p53). Among samples tested by both methods, there is strong concordance among large chromosomal changes, encompassing multiple cytological bands to whole chromosome lengths. For example, there is apparent whole chromosomal duplication of Chromosomes 6 and 15 in tumor C and of Chromosomes 8 and 18 in tumor H, monosomy of Chromosome 10 in tumor J, and loss of X Chromosome in tumors E and H (all or partial, respectively). Making comparisons among imbalances spanning shorter chromosome lengths was more difficult, mainly due to the challenge of reconciling cytological and physical maps. Furthermore, technical limitations may account for real differences between the two assays: small imbalances detected by one to several bacterial artificial chromosome (BAC) clones are irresolvable by cCGH; on the other hand, the relatively low density of BAC clones may not adequately sample smaller regions detected by cCGH. Nevertheless, on average, about five imbalances per tumor were detected by cCGH. This number is comparable to the number of changes observed in myelocytomatosis oncogene (c-myc)-induced mouse mammary tumors (Weaver et al. 1999) and human tumors (Ried et al. 1995), yet less than the number of changes seen in breast cancer 1 (Brca1)-deficient mouse tumors (8.0) and more than v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 (HER2/neu)-induced tumors (2.8) (Montagna et al. 2002; Weaver et al. 2002).
###end p 32
###begin title 33
Discussion
###end title 33
###begin title 34
Common Mechanisms for Tumor Progression in Epithelial Cells of Distinct Origin
###end title 34
###begin p 35
###xml 522 538 522 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Chen1">Chen et al. 1992</xref>
###xml 540 564 540 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Saenz-Robles1">Saenz-Robles et al. 1994</xref>
###xml 566 585 566 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Symonds3">Symonds et al. 1994</xref>
###xml 587 603 587 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Xiao1">Xiao et al. 2002</xref>
###xml 219 224 <span type="species:ncbi:10090">mouse</span>
Here we report that loss of pRb family function in mammary epithelium predisposes to malignant adenocarcinoma. Using a single transgenic allele, we have thus far inactivated the pRb pathway in several cell types in the mouse: brain choroid plexus epithelium, astrocytes, and mammary epithelium. In each case, despite the marked differences among these divergent cell types, pRb inactivation causes a similar response, initially evoking increased proliferation and apoptosis and, ultimately, predisposing to tumorigenesis (Chen et al. 1992; Saenz-Robles et al. 1994; Symonds et al. 1994; Xiao et al. 2002).
###end p 35
###begin p 36
###xml 195 214 195 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Symonds3">Symonds et al. 1994</xref>
###xml 216 230 216 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Lu1">Lu et al. 2001</xref>
###xml 333 334 333 334 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 398 413 398 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Li2">Li et al. 1996b</xref>
###xml 415 433 415 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Husler1">Husler et al. 1998</xref>
###xml 435 452 435 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Green1">Green et al. 2000</xref>
###xml 454 478 454 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Schulze-Garg1">Schulze-Garg et al. 2000</xref>
###xml 686 687 686 687 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 812 815 812 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 906 907 906 907 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 1069 1072 1069 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">not</italic>
###xml 1114 1115 1114 1115 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 1219 1220 1219 1220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 1331 1346 1331 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Li1">Li et al. 1996a</xref>
Not surprisingly, the long latency of mammary adenocarcinomas indicates that additional events are required for tumor progression. We show that mammary epithelium is similar to brain epithelium (Symonds et al. 1994; Lu et al. 2001) in its requirement for p53 activity in the apoptotic response to aberrant proliferation caused by pRbf inactivation. Previous models using wild-type large T antigen (Li et al. 1996b; Husler et al. 1998; Green et al. 2000; Schulze-Garg et al. 2000) are unable to address the relative contribution of pRb and p53, since T antigen also binds and inactivates p53. As in brain epithelium, we show here that when the mammary tumor phenotype is initiated by pRbf inactivation, most of the apoptosis is mediated through p53. Furthermore, as in brain epithelium, heterozygosity for a null p53 allele significantly shortens tumor latency (discussed further below). Importantly, the Rbf deficiency-induced apoptotic response and inhibition of tumor progression are not universally dependent on p53. In astrocytes, we recently showed that PTEN, and not p53, modulates these same responses to Rbf inactivation. In contrast to the p53-dependent apoptosis of mammary epithelial cells in response to pRbf deficiency, apoptosis associated with normal mammary involution subsequent to lactation does not require p53 (Li et al. 1996a). Thus, the "wiring" of the apoptotic response within this cell type is not global, but rather depends on the signal.
###end p 36
###begin p 37
###xml 104 107 104 107 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 111 114 111 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 99 114 99 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub>;p53<sup>+/&#8722;</sup></italic>
###xml 159 167 159 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v-Ha-ras</italic>
###xml 169 188 169 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Hundley1">Hundley et al. 1997</xref>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt-1</italic>
###xml 200 217 200 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Jones1">Jones et al. 1997</xref>
###xml 762 765 762 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 757 765 757 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
###xml 800 803 800 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 808 813 808 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt-1</italic>
###xml 860 863 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1075 1078 1075 1078 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
Although loss of p53-dependent apoptosis accounts for the acceleration of mammary tumorigenesis in WAP-T121;p53+/- mice, in models expressing either activated v-Ha-ras (Hundley et al. 1997) or Wnt-1 (Jones et al. 1997), earlier tumor formation in p53 heterozygous and homozygous null mice is accounted for by increased proliferation rather than attenuated apoptosis. An important caveat to this comparison is that the latter studies compared apoptosis in terminal tumors in which loss of apoptosis might have been selected regardless of initial p53 status, leaving open the possibility that tumor growth rates in these models reflect the combined effects of increased proliferation as well as reduced apoptosis. Nevertheless, there is a clear difference in WAP-T121 mammary gland in that, unlike the Ras and Wnt-1 models, proliferation levels do not depend on p53 status. Taken together, these observations indicate that the specific cellular response to an oncogenic stimulus depends on the nature of the initial insult. Given that the pRb pathway is directly disrupted in T121-expressing cells, this could be explained if these other initiating events evoke p53-dependent growth arrest which, in part, functions upstream of pRb.
###end p 37
###begin title 38
High Selective Pressure for p53 Inactivation in the Transition to Aggressive Mammary Adenocarcinoma
###end title 38
###begin p 39
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 141 147 141 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/+</sup></italic>
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 152 158 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 182 185 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 323 326 323 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 320 326 320 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 429 443 429 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Lu1">Lu et al. 2001</xref>
###xml 553 556 553 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 560 563 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 548 563 548 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub>;p53<sup>+/&#8722;</sup></italic>
###xml 716 719 716 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 762 776 762 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Lu1">Lu et al. 2001</xref>
###xml 905 908 905 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
Most of the apoptosis induced by pRbf deficiency in both mammary (75%) and brain (85%) epithelia is p53-dependent as determined by comparing p53+/+ and p53-/- tissue. However, while p53 heterozygosity had no impact on the level of apoptosis in the brain epithelium, in the mammary gland the level was reduced by half in p53+/- tissue. Given that apoptosis is the basis for selective inactivation of p53 in the brain tumor model (Lu et al. 2001; X. Lu and T. Van Dyke, unpublished data), it was possible that the pressure was relieved or reduced in WAP-T121;p53+/- mice. However, aggressive adenocarcinoma growth was accelerated with 100% penetrance, and 80% of these tumors underwent selective loss of the wild-type p53 allele, just as in the brain tumor model (Lu et al. 2001). This result indicates that tumor progression requires more than a simple reduction in the level of apoptosis; it follows that p53 may contribute to tumor suppression by multiple mechanisms.
###end p 39
###begin p 40
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 165 168 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 203 217 203 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Lu1">Lu et al. 2001</xref>
###xml 414 417 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 772 775 772 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 804 807 804 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 824 842 824 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Weaver2">Weaver et al. 2002</xref>
###xml 951 958 951 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">against</italic>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
While both mammary and brain carcinomas show high rates of p53 loss of heterozygosity (LOH), the mechanism of loss may be distinct. Chromosome loss clearly explains p53 LOH in the brain carcinoma model (Lu et al. 2001) where nearly all tumors (greater than 90%) are monosomic for Chromosome 11, whereas only a single mammary tumor analyzed by CGH showed Chromosome 11 loss. Alternative mechanisms that may explain p53 LOH in the mammary tumors include somatic recombination or chromosomal reduplication following mitotic nondisjunction. Whether these alternative routes of LOH represent bona fide tissue-specific phenomena or are due to relatively small sample sizes will require further analyses. Interestingly, most mammary tumors derived from Brca1-deficient mice lost p53; however, regions distal to p53 were amplified (Weaver et al. 2002). Thus, it is possible that mammary tumor promoting factor(s) is located on distal Chromosome 11, selecting against loss.
###end p 40
###begin title 41
Limited Chromosomal Instability in the Absence of p53
###end title 41
###begin p 42
###xml 406 409 406 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 403 409 403 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 451 465 451 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Lu1">Lu et al. 2001</xref>
###xml 728 731 728 731 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 42 47 <span type="species:ncbi:9606">human</span>
Genomic instability is a hallmark of most human solid tumors, and a widely held view is that p53 represses instability to suppress tumorigenesis, although evidence for this activity has been mostly correlative. Contrary to this model, we demonstrated previously that in the absence of p53 activity in brain epithelia, tumors progress without chromosomal instability; except for Chromosome 11 loss, in a p53+/- background these carcinomas are diploid (Lu et al. 2001). Here we show that mammary tumors similarly harbor limited genome-wide alterations. While the number of aberrations within the mammary tumors is small, it is intriguing that some changes are recurrent, suggesting that their accrual is causal in tumorigenesis. T121-induced mammary carcinomas harbor more genomic imbalances than brain tumors (approximately five versus approximately one). One explanation for this observation is that, because the brain is a vital organ, animals succumb to their illness when the brain tumor is at a relatively earlier stage at which fewer changes have accumulated. However, chromosome content of choroid plexus tumors passaged further in xenografts remained stable (X. Lu and T. Van Dyke, unpublished data). The converse experiment, analyses of early mammary tumors subsequent to p53 loss, will be required to determine the kinetics of chromosomal changes in this tissue.
###end p 42
###begin title 43
Pocket Protein Redundancy
###end title 43
###begin p 44
###xml 170 189 170 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Maandag1">Maandag et al. 1994</xref>
###xml 191 211 191 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Robinson1">Robinson et al. 2001</xref>
###xml 288 289 288 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 324 340 324 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Wang1">Wang et al. 1994</xref>
###xml 451 473 451 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Dannenberg1">Dannenberg et al. 2000</xref>
###xml 475 491 475 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Sage1">Sage et al. 2000</xref>
###xml 557 584 557 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Robanus-Maandag1">Robanus-Maandag et al. 1998</xref>
###xml 586 602 586 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Xiao1">Xiao et al. 2002</xref>
###xml 759 762 759 762 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 795 797 795 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1144 1160 1144 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Sage2">Sage et al. 2003</xref>
###xml 1441 1444 1441 1444 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 1436 1444 1436 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
###xml 538 544 <span type="species:ncbi:10090">murine</span>
###xml 1654 1659 <span type="species:ncbi:9606">human</span>
Chimera and tissue-grafting experiments with pRb-deficient cells indicate the absence of pRb alone is not sufficient for abnormal mammary development or tumor formation (Maandag et al. 1994; Robinson et al. 2001). Yet mammary-directed overexpression of CCND1, an upstream regulator of pRbf, leads to mammary adenocarcinoma (Wang et al. 1994). Given other recent studies indicating the possibility for compensation of pRb function by p107 and/or p130 (Dannenberg et al. 2000; Sage et al. 2000) and the clear redundancy of function in some murine cell types (Robanus-Maandag et al. 1998; Xiao et al. 2002), it is likely that the discrepancy among our results can be explained by overlapping functions of other family members, p107 and/or p130. In our studies, T121 abrogates the activities of all Rb family members by a dominant interfering mechanism. A subtly distinct alternative explanation is that the acute loss of pRb signaling, rather than a chronic loss as of pRb during mammary development, as in the chimera and grafting models, accounts for the difference. Cell culture experiments that support this hypothesis were recently reported (Sage et al. 2003). In this model, p107 and p130 may be more responsive to pRb regulatory signals during development than in the terminally differentiated tissue; therefore, the developing tissue more easily accommodates for the absence of pRb in the pool of available pocket proteins. In the WAP-T121 model, the gland undergoes normal development and then is subsequently subjected to acute pRb pathway loss. We presume that this scenario more closely mimics the situation of spontaneous somatic loss in adult human breast. The test of this alternative hypothesis awaits analyses of tissue-specific inactivation of pRb and the paralogous pocket proteins using conditional alleles.
###end p 44
###begin title 45
A Model for Mammary Tumorigenesis Initiated by Targeting the pRb Pathway
###end title 45
###begin p 46
###xml 9 12 9 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
###xml 272 277 272 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 269 277 269 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16<sup>INK4a</sup></italic>
###xml 309 332 309 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Krimpenfort1">Krimpenfort et al. 2001</xref>
###xml 334 355 334 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Sharpless1">Sharpless et al. 2001</xref>
###xml 434 450 434 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Wang1">Wang et al. 1994</xref>
###xml 744 748 744 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121 </sub>
###xml 888 891 888 891 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 997 1000 997 1000 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 992 1000 992 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
###xml 1187 1189 1187 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1236 1241 1236 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1246 1251 1246 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 1302 1305 1302 1305 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 1297 1305 1297 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
###xml 208 213 <span type="species:ncbi:9606">human</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 810 816 <span type="species:ncbi:10090">murine</span>
###xml 1359 1364 <span type="species:ncbi:9606">human</span>
The WAP-T121 model is a significant addition to the current repertoire of preclinical mammary tumor models exploring the role of pRb pathway in tumorigenesis. Despite the prevalence of pRb pathway defects in human sporadic cancers, mice harboring germline mutations of p16INK4a do not develop mammary cancer (Krimpenfort et al. 2001; Sharpless et al. 2001). In addition, mammary-directed expression of CCND1 is only mildly oncogenic (Wang et al. 1994), and as mentioned above, inactivation of pRb alone is not sufficient for tumorigenesis. Although the WAP promoter was a convenient means of directing mammary-specific expression for an initial assessment this model, it also presents the major shortcoming to this model in that expression of T121 is linked to lactogenic hormone activity, as in most existing murine mammary tumor models. Future improvements aim to direct expression of T121 through hormone-independent methods. Finally, the advantage over wild-type T antigen models is that WAP-T121 uncouples the simultaneous inactivation of pRb and p53 and permits an assessment of the relative contributions of the individual oncogenic pathways. Testing the combinatorial effects of Rb loss and other breast cancer mutations (e.g., BRCA1 and BRCA2), along with the further characterization of WAP-T121 tumors, should help provide additional insights into human breast cancer biology.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48

###end title 48
###begin title 49
###xml 35 50 <span type="species:ncbi:10090">transgenic mice</span>
Derivation and characterization of transgenic mice.
###end title 49
###begin p 50
###xml 158 178 154 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Sandgren1">Sandgren et al. 1995</xref>
###xml 243 245 239 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dl</italic>
###xml 261 277 257 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Chen1">Chen et al. 1992</xref>
###xml 293 296 289 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 416 435 412 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Pittius1">Pittius et al. 1988</xref>
###xml 442 450 438 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g001">Figure 1</xref>
###xml 454 457 450 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 520 528 516 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g001">Figure 1</xref>
###xml 657 658 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 669 689 665 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-DeCaprio1">DeCaprio et al. 1989</xref>
###xml 691 708 687 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Dyson2">Dyson et al. 1989</xref>
###xml 710 726 706 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Ewen1">Ewen et al. 1989</xref>
###xml 833 851 829 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Husler1">Husler et al. 1998</xref>
###xml 853 870 849 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Green1">Green et al. 2000</xref>
###xml 872 896 868 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Schulze-Garg1">Schulze-Garg et al. 2000</xref>
###xml 1139 1156 1135 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Goetz1">Goetz et al. 2001</xref>
###xml 1312 1313 1308 1309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
###xml 1456 1464 1452 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g001">Figure 1</xref>
###xml 1639 1654 1634 1649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Yan1">Yan et al. 1990</xref>
###xml 2015 2018 1980 1983 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 2008 2018 1973 1983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TgWAP-T<sub>121</sub></italic>
###xml 2155 2158 2120 2123 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 2217 2220 2182 2185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 2212 2220 2177 2185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
###xml 2384 2385 2349 2350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2396 2397 2361 2362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2412 2413 2377 2378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2614 2633 2579 2598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Pittius1">Pittius et al. 1988</xref>
###xml 500 504 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 814 818 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1609 1613 <span type="species:ncbi:10090">mice</span>
###xml 1657 1672 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 2019 2024 <span type="species:ncbi:10090">mouse</span>
###xml 2083 2087 <span type="species:ncbi:10090">mice</span>
###xml 2283 2287 <span type="species:ncbi:10090">mice</span>
###xml 2357 2361 <span type="species:ncbi:10090">mice</span>
###xml 2430 2434 <span type="species:ncbi:10090">mice</span>
###xml 2464 2468 <span type="species:ncbi:10090">mice</span>
###xml 2516 2520 <span type="species:ncbi:10090">mice</span>
The 2.4 kb WAP promoter region was isolated from a WAP-TGFalpha construct (a gift from David Lee, University of North Carolina at Chapel Hill, United States [Sandgren et al. 1995]) and was cloned upstream of a 2.4 kb KpnI-SalI fragment of the dl1137't plasmid (Chen et al. 1992). We targeted T121 expression to mammary gland using the WAP promoter, which is induced late in pregnancy and expressed during lactation (Pittius et al. 1988) (see Figure 1). T121 contains the first 121 amino acids of the SV40 T antigen (see Figure 1) that encodes a J domain and a pRb-binding domain, which together are sufficient to cause transformation by inactivating the pRbf proteins (DeCaprio et al. 1989; Dyson et al. 1989; Ewen et al. 1989). Importantly, in contrast to other wild-type T antigen constructs encoding the entire SV40 early region (Husler et al. 1998; Green et al. 2000; Schulze-Garg et al. 2000), small t antigen expression is absent due to a deletion that removes the splice acceptor site. The importance of this is demonstrated by the recent observation that small t antigen alone is sufficient for tumorigenesis in the mammary gland (Goetz et al. 2001). Furthermore, p53 and EP300 (E1A-binding protein p300), which map to the carboxyl half of T antigen, are also abolished, thus permitting assessment of pRbf inactivation without the confounding effects of altering additional suppressor pathways. An EcoRI fragment containing the full transgene (see Figure 1) at a concentration of 4 ng/mul was injected in to fertilized eggs harvested from B6D2F1 (Jackson Laboratory, Bar Harbor, Maine, United States) mice as described previously (Yan et al. 1990). Transgenic mice were identified by PCR amplification of a 160 bp fragment using primers 5'-GAATCTTTGCAGCTAATGGACC-3' and 5'-GCATCCCAGAAGCTCCAAAG-3' with toe-derived genomic DNA as template. Cycling profile was as follows: 94degreesC, 2 min; 35 cycles of 94degreesC, 20 s; 62degreesC, 45 s; 72degreesC, 45 s; and final incubation of 72degreesC, 2 min. TgWAP-T121 mouse lines were maintained by crossing to nontransgenic B6D2F1 mice (Jackson Laboratory) and therefore are designated as B6;D2-Tg(WAP-T121) Tvd. To study the effect of background differences, WAP-T121 males were backcrossed to BALB/cJ (Jackson Laboratory) female mice. To increase sample size, tumor onset analysis for BALB/c background mice combined data for N6 (n = 6), N7 (n = 1), and N9 (n = 4) generation mice. For tumor induction, female mice, unless noted as virgin, were housed with male mice to maximize the number of pregnancies, because WAP promoter activity is lactation-dependent (Pittius et al. 1988).
###end p 50
###begin p 51
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 69 72 69 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 64 72 64 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 89 93 89 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121<sup>+</sup></sub>
###xml 84 93 84 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121<sup>+</sup></sub></italic>
###xml 116 119 116 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 113 119 113 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 132 138 132 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Tyj</sup>
###xml 129 138 129 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>tm1Tyj</sup></italic>
###xml 161 164 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 219 235 219 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Lowe1">Lowe et al. 1993</xref>
###xml 332 335 332 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 429 432 429 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 569 572 569 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 564 572 564 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
###xml 614 615 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 611 615 611 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121<sup>&#8722;</sup></sub>
###xml 619 622 619 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 606 622 606 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121<sup>&#8722;</sup></sub>;p53<sup>+/&#8722;</sup></italic>
###xml 633 634 633 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 630 634 630 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121<sup>+</sup></sub>
###xml 638 641 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 625 642 625 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121<sup>+</sup></sub>;p53<sup>+/&#8722;</sup>,</italic>
###xml 683 686 683 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 680 686 680 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/+</sup></italic>
###xml 691 694 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 688 694 688 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 702 705 702 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 699 705 699 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
To study the effect of p53 mutation on mammary tumorigenesis in WAP-T121 mice, male WAP-T121+ mice were mated to p53+/- females (p53tm1Tyj; Jackson Laboratory). p53 genotypes were determined by PCR using two reactions (Lowe et al. 1993), one that amplifies the neomycin insertion site (neomycin primer: 5'- TCCTCGTGCTTTACGGTATC-3', p53 primer: 5'-TATACTCAGAGCCGGCCT-3'; 525 bp product) and a second that amplifies the endogenous p53 allele (substituting 5'-ACAGCGTGGTGGTACCTTAT-3' for the neo primer, 475 bp product). Cycling parameters were the same as the above WAP-T121 reaction. We performed the cross WAP-T121-;p53+/- x WAP-T121+;p53+/-, and transgenic female mice that were p53+/+, p53+/-, or p53-/- were used for analyses while nontransgenic littermates served as controls.
###end p 51
###begin title 52
Western immunoblotting analysis.
###end title 52
###begin p 53
###xml 64 83 64 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Symonds2">Symonds et al. 1993</xref>
###xml 233 236 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 568 587 565 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Symonds1">Symonds et al. 1991</xref>
###xml 748 766 745 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Harlow1">Harlow et al. 1981</xref>
###xml 269 276 <span type="species:ncbi:3879">Lucerne</span>
###xml 624 630 <span type="species:ncbi:9913">bovine</span>
###xml 699 703 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 845 856 <span type="species:ncbi:3704">horseradish</span>
###xml 879 883 <span type="species:ncbi:9925">goat</span>
###xml 889 894 <span type="species:ncbi:10090">mouse</span>
Protein expression levels were assayed as previously described (Symonds et al. 1993). Fresh or flash-frozen tissue samples were homogenized in lysis buffer (50 mM Tris [pH 8.0], 5 mM EDTA, 150 mM NaCl , and 1% NP-40) using a Polytron(R) homogenizer (Kinematica, Littau-Lucerne, Switzerland). Total protein (10 mug) was electrophoresed through a 15% polyacrylamide denaturing gel and then transferred to nitrocellulose membrane (15 V, 30 min). Alternatively, for low-expressing lines, immunoprecipitation was performed prior to electrophoresis as previously described (Symonds et al. 1991). The filter was preincubated in 3% bovine serum albumin, followed by incubation with primary antibody against SV40 T antigen (PAb419 at a dilution of 1:5,000; Harlow et al. 1981). The filter was then washed, followed by incubation at room temperature with horseradish peroxidase-conjugated goat anti-mouse IgG (Amersham Biosciences, Little Chalfont, United Kingdom). The enhanced chemiluminescence method (Amersham Biosciences) was used for autoradiography.
###end p 53
###begin title 54
Histopathology and immunohistochemistry.
###end title 54
###begin p 55
###xml 58 61 58 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
###xml 523 543 522 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Gavrieli1">Gavrieli et al. 1992</xref>
###xml 573 593 572 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Symonds3">Symonds et al. (1994</xref>
Mammary tissue and tumor samples were dissected from WAP-T121 transgenic or age- and parity-matched B6D2F1 animals. A portion of each tumor was flash-frozen in liquid nitrogen and the remaining tissue was fixed in 10% phosphate buffered formalin, embedded in paraffin, cut to a 5-mum thickness, and stained with hemotoxylin and eosin or immunostained using the Vector ABC system (Vector Laboratories, Burlingame, California, United States) for histopathological examination. Apoptosis levels were evaluated by TUNEL assay (Gavrieli et al. 1992) essentially as described in Symonds et al. (1994).
###end p 55
###begin title 56
Real-time PCR.
###end title 56
###begin p 57
###xml 151 154 151 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 187 201 187 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Lu1">Lu et al. 2001</xref>
###xml 224 227 224 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 321 324 321 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 405 415 405 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 505 515 502 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 626 629 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 645 655 638 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 1321 1322 1270 1271 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 1334 1340 1283 1289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t(p53)</sub>
###xml 1351 1353 1300 1302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t(</sub>
###xml 1353 1363 1302 1309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</sub>
###xml 1353 1363 1302 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>&#946;-actin</sub></italic>
###xml 1363 1364 1309 1310 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</sub>
###xml 1372 1375 1318 1321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1386 1391 1332 1337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(p53)</sub>
###xml 1397 1400 1343 1346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1411 1412 1357 1358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</sub>
###xml 1412 1422 1358 1365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</sub>
###xml 1412 1422 1358 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>&#946;-actin</sub></italic>
###xml 1422 1423 1365 1366 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</sub>
###xml 1433 1434 1376 1377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 1699 1708 1642 1647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;Ctn</sup>
Quantitative real-time PCR analysis was performed using a TaqMan approach on DNA derived from terminal tumors to determine the status of the wild-type p53 allele as previously described (Lu et al. 2001). The primers for the p53 allele were 5'-ATGGCCATCTACAAGAAGTCACAG-3' and 5'-ATCGGAGCAGCGCTCATG-3'. The sequence of the p53 probe was 5'-ACATGACGGAGGTCGTGAGACGCTG-3'. The primers for the internal control beta-actin gene were 5'-AAGAGCTATGAGCTGCCTGA-3' and 5'-ACGGATGTCAACGTCACACT-3'. The sequence of the beta-actin probe was 5'-CACTATTGGCAACGAGCGGTTCCG-3'. Each 25-mul reaction mixture contained 50 ng of DNA template, 18 nM p53 primers, 80 nM beta-actin primers, 8 nM probe, and 12.5 mul of TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, California, United States) containing AmpliTaq Gold polymerase, deoxynucleoside triphosphates, and PCR buffer. The cycling conditions were 50degreesC for 2 min and 95degreesC for 10 min for 1 cycle, and 95degreesC for 15 s and 60degreesC for 1 min for 40 cycles. The reactions were performed using an ABI 7700 Sequence Detection system (Applied Biosystems), and the data analyzed using Sequence Detector 1.7 (Applied Biosystems) and standard protocols (). The copy number of each sample was determined by calculating DeltaDeltaCt based on the formula DeltaDeltaCt = [sample Ct(p53) - sample Ct(beta-actin)] - [p53+/+ control Ct(p53) - p53+/+ control Ct(beta-actin)], where Ct is the number of cycles required to reach a threshold based on linear amplification. Analyses of standard samples (L. Chin, Harvard University, Cambridge, Massachusetts, United States, personal communication) indicate copy numbers of 2, 1, and 0 are indicated by 2-DeltaCtn values of greater than 0.6, 0.15-0.6, and less than 0.15, respectively. Standard samples analyzed along with experimental samples confirmed the accuracy of these assignments.
###end p 57
###begin title 58
Statistical analyses.
###end title 58
###begin p 59
Kaplan-Meier survival analysis was used to determine median tumor latencies (StatsDirect, Camcode, Sale, United Kingdom), and the Log-Rank (Peto, StatsDirect) test was performed to evaluate significance. The equivalence of tumor morphology distributions was tested using the Fisher-Freeman-Halton's exact test.
###end p 59
###begin title 60
CGH.
###end title 60
###begin p 61
###xml 290 291 290 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 329 353 329 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Kallioniemi1">Kallioniemi et al. (1992</xref>
###xml 356 378 356 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Donehower1">Donehower et al. (1995</xref>
###xml 385 400 385 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Lu1">Lu et al. (2001</xref>
###xml 438 459 438 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Snijders1">Snijders et al. (2001</xref>
###xml 598 603 598 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cot-1</italic>
###xml 1084 1087 1084 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SKY</italic>
###xml 712 717 <span type="species:ncbi:10090">mouse</span>
###xml 1200 1205 <span type="species:ncbi:10090">mouse</span>
Genomic DNA was extracted from end-stage tumors (1 cm in diameter) or tails using a DNeasy genomic tip (Qiagen, Valencia, California, United States) and further purified by proteinase K digestion followed by phenol/chloroform extraction, ethanol precipitation, and resuspension in sterile H2O. cCGH was performed as described in Kallioniemi et al. (1992), Donehower et al. (1995), and Lu et al. (2001). aCGH was performed as described in Snijders et al. (2001). For both methods, genomic DNA from tumor and normal tissue was labeled with different fluorochromes and then cohybridized together with Cot-1 DNA to either normal metaphase chromosomes from cultured cells (cCGH) or microarrayed BAC clones containing mouse genomic DNA (aCGH). Nonequivalent fluorescence intensities indicate relative imbalances of genomic DNA. Aneuploidy and partial chromosome gains and losses are detectable by cCGH with approximately 10 Mb resolution. Graphical output of cCGH data was generated using the National Cancer Institute and National Center for Biotechnology Information Spectral Karyotyping SKY and Comparative Genomic Hybridization CGH Database (). For aCGH, approximately 1,500 BAC clones span the entire mouse genome with 2-20 Mb spacing. Tumor DNA and normal DNA were sex-mismatched; thus, the X Chromosome served as an internal control, while normal tail DNA was used as a negative control. Gains or losses were scored based on tumor:normal fluorescence ratios that were greater than 1.25 or less than 0.75, respectively.
###end p 61
###begin title 62
Supporting Information
###end title 62
###begin title 63

###end title 63
###begin title 64
Accession Numbers
###end title 64
###begin p 65
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-myc</italic>
###xml 309 312 309 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neu</italic>
###xml 379 384 379 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 561 565 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 588 595 588 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Ha-ras</italic>
###xml 647 652 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt-1</italic>
The accession numbers for the genes and gene products discussed in this paper are Brca1 (LocusLink ID 12189), CDK2 (LocusLink ID 1017), CDK4 (LocusLink ID 1019), CDK6 (LocusLink ID 1021), c-myc (LocusLink ID 17869), cyclin D1 (LocusLink ID 595), cyclin E (LocusLink ID 898), E2F (InterPro ID IPR003316), HER2/neu (LocusLink ID 13866), histone deacetylase (LocusLink ID 3065), p16INK4a (LocusLink ID 1029), p53 (LocusLink ID 7157), p107 (LocusLink ID 5933), p130 (LocusLink ID 5934), p300 (LocusLink ID 2033), PCNA (LocusLink ID 18538), pRb (LocusLink ID 5925), PTEN (LocusLink ID 5728), v-Ha-ras (LocusLink ID 3265), WAP (LocusLink ID 22373), and Wnt-1 (LocusLink ID 22408).
###end p 65
###begin p 66
These databases may be found at  (LocusLink), and  (InterPro).
###end p 66
###begin p 67
###xml 176 179 176 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 171 179 171 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
The authors thank Lisa Livanos at the University of North Carolina (UNC) chromosome imaging core facility for assistance with cCGH; Joe McCarville for the assembly of the WAP-T121 construct; Drew Fogarty and Anne Wolthusen for expert technical assistance; the UNC histopathology core facility; the UNC Division of Laboratory Animal Medicine; Bing Huey for aCGH; and Karl Sirotkin and Vasuki Gobu at the National Center for Biotechnology Information for their assistance with cCGH data submission. We also thank Xiangdong Lu and Dale Cowley for their critical reading of the manuscript. KS was supported by a National Cancer Institute postdoctoral training grant (T32CA09156) to the Lineberger Comprehensive Cancer Center. This work was also supported by grants from the Susan G. Komen Breast Cancer Foundation (BCTR98), the United States Army (DAMD17-99-1-9332), and two grants from the National Cancer Institute, to TVD (5 R01 CA46283-15) and to DA (CA84118).
###end p 67
###begin title 68
References
###end title 68
###begin article-title 69
Retinoblastoma protein recruits histone deacetylase to repress transcription
###end article-title 69
###begin article-title 70
###xml 48 53 <span type="species:ncbi:9606">human</span>
Expression and amplification of cyclin genes in human breast cancer
###end article-title 70
###begin article-title 71
###xml 31 46 <span type="species:ncbi:10090">transgenic mice</span>
T antigen mutant activities in transgenic mice: Roles of p53 and pRb-binding in tumorigenesis of the choroid plexus
###end article-title 71
###begin article-title 72
Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions
###end article-title 72
###begin article-title 73
The product of the retinoblastoma susceptibility gene has properties of a cell-cycle regulatory element
###end article-title 73
###begin article-title 74
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt-1</italic>
###xml 61 76 <span type="species:ncbi:10090">transgenic mice</span>
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability
###end article-title 74
###begin article-title 75
The regulation of E2F by pRb-family proteins
###end article-title 75
###begin article-title 76
###xml 100 104 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 109 117 <span type="species:ncbi:10632">JC virus</span>
The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus
###end article-title 76
###begin article-title 77
###xml 51 55 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120
###end article-title 77
###begin article-title 78
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
Identification of programmed cell death in situ via specific labeling of nuclear fragmentation
###end article-title 78
###begin article-title 79
###xml 30 35 30 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4A</sup>
###xml 50 55 <span type="species:ncbi:9606">human</span>
High frequency of aberrant p16INK4A expression in human breast cancer
###end article-title 79
###begin article-title 80
###xml 4 8 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 103 118 <span type="species:ncbi:10090">transgenic mice</span>
The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice: Truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect
###end article-title 80
###begin article-title 81
###xml 10 14 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: Ductal epithelial cell targeting with multistage progression to carcinoma
###end article-title 81
###begin article-title 82
Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
###end article-title 82
###begin article-title 83
The retinoblastoma protein and cell-cycle regulation
###end article-title 83
###begin article-title 84
###xml 35 50 <span type="species:ncbi:10633">simian virus 40</span>
Monoclonal antibodies specific for simian virus 40 tumor antigens
###end article-title 84
###begin article-title 85
###xml 85 89 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53
###end article-title 85
###begin article-title 86
###xml 18 26 18 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-SV40</italic>
###xml 22 26 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Lactation-induced WAP-SV40 Tag transgene expression in C57BL/6J mice leads to mammary carcinoma
###end article-title 86
###begin article-title 87
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Tumor spectrum analysis in p53-mutant mice
###end article-title 87
###begin article-title 88
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis
###end article-title 88
###begin article-title 89
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
###end article-title 89
###begin article-title 90
###xml 11 16 11 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
###end article-title 90
###begin article-title 91
Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways
###end article-title 91
###begin article-title 92
Expression of a viral oncoprotein during mammary gland development alters cell fate and function: Induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells
###end article-title 92
###begin article-title 93
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
p53 is required for radiation-induced apoptosis in mouse thymocytes
###end article-title 93
###begin article-title 94
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability
###end article-title 94
###begin article-title 95
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
Rb interacts with histone deacetylase to repress transcription
###end article-title 95
###begin article-title 96
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice
###end article-title 96
###begin article-title 97
Retinoblastoma protein represses transcription by recruiting a histone deacetylase
###end article-title 97
###begin article-title 98
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum
###end article-title 98
###begin article-title 99
Tumor suppressor genes
###end article-title 99
###begin article-title 100
###xml 97 100 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neu</italic>
###xml 167 170 167 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neu</italic>
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu
###end article-title 100
###begin article-title 101
Retinoblastoma protein partners
###end article-title 101
###begin article-title 102
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 43 48 <span type="species:ncbi:9606">human</span>
Mutations in the p53 gene occur in diverse human tumor types
###end article-title 102
###begin article-title 103
Cyclin D-dependent kinases, INK4 inhibitors and cancer
###end article-title 103
###begin article-title 104
High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays
###end article-title 104
###begin article-title 105
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 119 134 <span type="species:ncbi:10090">transgenic mice</span>
A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice
###end article-title 105
###begin article-title 106
Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas
###end article-title 106
###begin article-title 107
###xml 68 72 <span type="species:ncbi:10090">mice</span>
p107 is a suppressor of retinoblastoma development in pRb-deficient mice
###end article-title 107
###begin article-title 108
Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene
###end article-title 108
###begin article-title 109
###xml 122 137 <span type="species:ncbi:10633">simian virus 40</span>
Induction versus progression of brain tumor development: Differential functions for the pRb- and p53-targeting domains of simian virus 40 T antigen
###end article-title 109
###begin article-title 110
Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization
###end article-title 110
###begin article-title 111
Acute mutation of retinoblastoma gene function is sufficient for cell cycle reentry
###end article-title 111
###begin article-title 112
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 130 145 <span type="species:ncbi:10090">transgenic mice</span>
Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice
###end article-title 112
###begin article-title 113
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland
###end article-title 113
###begin article-title 114
###xml 11 16 11 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
###end article-title 114
###begin article-title 115
Cancer cell cycles
###end article-title 115
###begin article-title 116
The Rb and p53 pathways in cancer
###end article-title 116
###begin article-title 117
Assembly of microarrays for genome-wide measurement of DNA copy number
###end article-title 117
###begin article-title 118
Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances
###end article-title 118
###begin article-title 119
###xml 79 94 <span type="species:ncbi:10633">simian virus 40</span>
Inactivation of pRb-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen
###end article-title 119
###begin article-title 120
###xml 122 137 <span type="species:ncbi:10633">simian virus 40</span>
Species-specific elements in the large T-antigen J domain are required for cellular transformation and DNA replication by simian virus 40
###end article-title 120
###begin article-title 121
###xml 30 54 <span type="species:ncbi:12480">lymphotropic papovavirus</span>
Complex formation between the lymphotropic papovavirus large tumor antigen and the tumor suppressor protein, p53
###end article-title 121
###begin article-title 122
###xml 7 22 <span type="species:ncbi:10090">transgenic mice</span>
###xml 65 80 <span type="species:ncbi:10633">simian virus 40</span>
Use of transgenic mice reveals cell-specific transformation by a simian virus 40 T-antigen amino-terminal mutant
###end article-title 122
###begin article-title 123
p53-dependent apoptosis suppresses tumor growth and progression in vivo
###end article-title 123
###begin article-title 124
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation
###end article-title 124
###begin article-title 125
###xml 37 41 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 52 67 <span type="species:ncbi:10090">transgenic mice</span>
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
###end article-title 125
###begin article-title 126
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 74 78 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 85 100 <span type="species:ncbi:10090">transgenic mice</span>
A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-c-myc transgenic mice
###end article-title 126
###begin article-title 127
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer
###end article-title 127
###begin article-title 128
The retinoblastoma protein and cell cycle control
###end article-title 128
###begin article-title 129
Retinoblastoma protein switches the E2F site from positive to negative element
###end article-title 129
###begin article-title 130
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences
###end article-title 130
###begin article-title 131
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation
###end article-title 131
###begin article-title 132
###xml 121 136 <span type="species:ncbi:10090">transgenic mice</span>
Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice
###end article-title 132
###begin title 133
Abbreviations
###end title 133
###begin p 134
microarray comparative genomic hybridization
###end p 134
###begin p 135
bacterial artificial chromosome
###end p 135
###begin p 136
breast cancer 1
###end p 136
###begin p 137
chromosome comparative genomic hybridization
###end p 137
###begin p 138
cyclin D1
###end p 138
###begin p 139
cyclin E1
###end p 139
###begin p 140
cyclin-dependent kinase 2
###end p 140
###begin p 141
cyclin-dependent kinase 4
###end p 141
###begin p 142
cyclin-dependent kinase 6
###end p 142
###begin p 143
comparative genomic hybridization
###end p 143
###begin p 144
myelocytomatosis oncogene
###end p 144
###begin p 145
loss of heterozygosity
###end p 145
###begin p 146
###xml 0 6 <span type="species:ncbi:10090">murine</span>
murine mammary tumor virus
###end p 146
###begin p 147
cyclin-dependent kinase inhibitor 2A
###end p 147
###begin p 148
proliferating cell nuclear antigen
###end p 148
###begin p 149
retinoblastoma 1
###end p 149
###begin p 150
retinoblastoma protein family
###end p 150
###begin p 151
phosphatase and tensin homolog
###end p 151
###begin p 152
###xml 0 15 <span type="species:ncbi:10633">simian virus 40</span>
simian virus 40
###end p 152
###begin p 153
erythroblastic leukemia viral oncogene homolog 2
###end p 153
###begin p 154
###xml 7 10 <span type="species:ncbi:10116">rat</span>
Harvey rat sarcoma viral oncogene
###end p 154
###begin p 155
whey acidic protein
###end p 155
###begin p 156
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wingless</italic>
###xml 17 21 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
wingless-related MMTV integration site 1
###end p 156
###begin title 157
Figures and Tables
###end title 157
###begin title 158
###xml 20 23 20 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 15 23 15 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
Diagram of the WAP-T121 Transgene and Protein
###end title 158
###begin p 159
###xml 229 231 229 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dl</italic>
###xml 358 379 358 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 74 78 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The fragment consists of the 2.4 kb WAP promoter (hatched) and the mutant SV40 T-antigen coding region (white box) containing two deletions, the 196-bp amino-terminal deletion, which abolishes small t antigen production, and the dl1137 deletion, which truncates T antigen. Both the J domain and the LXCXE domain are required for pRb family inactivation (see Materials and Methods).
###end p 159
###begin title 160
###xml 15 18 15 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 35 38 35 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
###xml 39 43 <span type="species:ncbi:10090">Mice</span>
Expression of T121 Protein in WAP-T121 Mice and a Summary of Gross Phenotypes
###end title 160
###begin p 161
###xml 532 535 532 535 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 826 847 826 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 982 985 982 985 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 180 184 <span type="species:ncbi:10090">Mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
As expected, each line showed mammary-specific expression following lactation induction, while line 4 showed more widespread expression, with protein detected in brain and kidney. Mice from the higher-expressing lines 3 and 4 failed to nurse because of lactation defects. Mammary glands of adult female mice from all four lines showed elevated proliferation and apoptosis. Glands from line 1 and 2 mice were hyperplastic, while glands from lines 3 and 4 were atrophic. Lines 3 and 4 later developed carcinomas and other neoplasms. T121 protein was detected by Western blot analysis in lactating mammary glands of animals from all four lines (B), although the lower-expressing lines 1 and 2 required immunoprecipitation with anti-T-antigen antibody prior to Western blot analysis (right panel in [B]). Brain tumor extract (see Materials and Methods) was used for a positive control, and nontransgenic mammary tissue extract was used for a negative control. A timecourse analysis of T121 expression (C) shows lactation-induced expression peaking at 5 d postpartum.
###end p 161
###begin p 162
###xml 0 14 0 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Abbreviations:</bold>
Abbreviations: Adeno-Ca, adenocarcinoma; AP, elevated apoptosis in mammary gland; At, atrophy; dpc, postcoital; FTN, failure to nurse; Hyp, hyperplastic acini; MG, mammary gland; MIN, mammary epithelia neoplasia; ND, not determined; nt, nontransgenic; pp, postpartum; Pr, elevated proliferation in mammary gland; pw, post-weaning.
###end p 162
###begin p 163
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> Footnotes:</bold>
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
 Footnotes:aMosaic founder animal.bAt earlier stages, development defects attributed to atrophy, while MIN and adenocarcinoma were observed at terminal stages.cApproximately half of progeny died of unknown cause.
###end p 163
###begin title 164
Mammary-Specific Inactivation of the pRb Pathway Induces Extensive Abnormalities
###end title 164
###begin p 165
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 90 91 90 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 146 149 146 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 541 544 541 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 859 862 859 862 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 914 915 914 915 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 1028 1029 1028 1029 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1175 1176 1175 1176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Histologic comparisons of nontransgenic (A-D), mosaic (F0 line 2 [E-H]), and transgenic (F1, line 3 [I-L]) lactating mammary glands reveals that T121 expression results in increased proliferation and apoptosis. Hemotoxylin and eosin staining shows acini of the normal lactating gland are composed of a single layer of secretory epithelial cells (A) with milk-filled lumen. Consistent with atrophy, transgenic animals have a lower density of acini demonstrated by the presence of lipid-filled adipocytes (asterisk in [K]). Acini composed of T121-expressing cells are atypical. Many are collapsed and composed of tall columnar epithelia of large hyperchromatic cells with papillary tufting (arrows in [I]). Transgene-expressing cells have large pleomorphic nuclei (open arrows in [G]) as compared to nuclei of nonexpressing cells (arrows in [G]). Staining for T121 expression (blue in [B]-[J]) indicates the line 2 F0 animal is mosaic, showing localized expression (F), whereas the transgene expresses throughout the gland of an F1 line 3 animal (J). Increased proliferation assayed by PCNA staining (red) is also localized in the mosaic founder (G), but found throughout the F1 transgenic gland (K). Similarly, TUNEL staining (brown) demonstrates increased apoptosis in transgenic animals (H and L); moreover, the regionalized apoptosis in the mosaic gland (H) strongly suggests that transgene expression and not precocious involution is the cause. All samples are from primiparous females on lactation day 1.
###end p 165
###begin title 166
Reduced p53 Activity Decreases Apoptosis but Does Not Increase Proliferation
###end title 166
###begin p 167
###xml 67 70 67 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 293 296 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 337 340 337 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 374 377 374 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 595 598 595 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
Representative apoptosis levels of each mouse line correlate with T121 expression as indicated by the percentage of TUNEL positive cells (A). Decreasing levels of p53 activity correlate with lower levels of apoptosis in transgenic mammary glands (B). The mean percentage of apoptotic cells in p53 wild-type transgenic glands was 21%; in p53 heterozygous animals, 9%; and in p53 null animals, 5% (B), indicating that 75% of the apoptosis is p53-dependent. Apoptosis levels are further reduced to 2% in terminal stage tumors (B, Tumors). The percentage of PCNA staining cells remains unchanged in p53 heterozygous or nullizygous animals (C), indicating that reduction of p53 activity levels had no significant impact on cell proliferation. Samples were derived from primiparous animals on lactation day 1, except as indicated as tumor samples (B). Transgenic animals in (B) and (C) were from line 3.
###end p 167
###begin title 168
Mammary Tumor Onset and Growth Are Accelerated by p53 Reduction
###end title 168
###begin p 169
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 194 200 194 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 292 293 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 454 455 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 543 544 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 560 565 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T</italic>
###xml 565 568 565 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 565 568 565 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>121</sub></italic>
###xml 572 575 572 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 568 575 568 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;p53<sup>+/&#8722;</sup></italic>
###xml 597 602 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T</italic>
###xml 602 605 602 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 602 605 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>121</sub></italic>
###xml 609 612 609 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 605 612 605 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;p53<sup>+/&#8722;</sup></italic>
###xml 641 644 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 705 708 705 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 702 708 702 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/+</sup></italic>
###xml 730 733 730 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 727 733 727 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
Among line 3 animals, the median time following initial transgene induction until a palpable tumor appeared was 10 mo, and within 16 mo, all mice developed palpable tumors (red line in [A]). In p53+/- transgenic animals (blue line in [A]), mammary tumors were detected significantly earlier (p < 0.0003) with a median onset of 6 mo. Among mice with BALB/cJ background (black line in [A]), median mammary tumor latency (8.5 mo) was significantly shorter (p = 0.0077) compared to mice of the hybrid BDF1 background strain and indistinguishable (p = 0.2466) from WAP-T121;p53+/- mice. Once palpable, WAP-T121;p53+/- tumors grew faster than the p53 wild-type counterparts (B). The average growth rates for p53+/+ (black solid) and p53+/- (dashed) are indicated.
###end p 169
###begin title 170
Tumor Morphologies
###end title 170
###begin p 171
###xml 39 42 39 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 34 42 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T</italic>
###xml 62 65 62 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>121</sub></italic>
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 111 114 111 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 106 114 106 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub></italic>
###xml 527 530 527 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 758 766 758 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020022-g003">Figure 3</xref>
Hemotoxylin and eosin staining of WAP-T121 (C and D) and WAP-T121p53+/- (A and B) (also representative of WAP-T121) tumor sections shows that terminal stage adenocarcinomas have varied morphologies. Poorly differentiated solid tumors were comprised of nests (A) or cords of epithelial cells (Tu) that infiltrate a fibrous stroma and were accompanied by necrosis (arrow) and strong immune response (arrowheads). Moderately differentiated glandular tumors (B) consisted of irregular, disorganized glands. In animals of wild-type p53 background, four pilar tumors (C), distinguished by swirls of laminar acellular keratin (arrow), and a single spindle cell carcinoma (D) were also observed. For comparison, a lactating gland from a wild-type animal is shown in Figure 3A. The percentage of animals displaying each of the phenotypes is summarized in (G). Since many tumors shared multiple morphologies, the sum exceeds 100%.
###end p 171
###begin title 172
CGH Analysis Shows Limited Genomic Instability
###end title 172
###begin p 173
###xml 1300 1303 1300 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1324 1327 1324 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1361 1364 1361 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
Twelve tumors were analyzed by CGH: ten by cCGH (Panel I, A-J), eight by aCGH (Panel II, B, C, E, and H-L), and six by both procedures (Panels I and II, B, C, E, and H-J). In Panel I, green and red lines adjacent to the ideograms indicate relative gain or loss, respectively. Tumor sample identities are indicated by letters above gain and loss lines. Only a single sample (Panel I, D) shows loss of Chromosome 11. Telomeric sequences of many chromosomes are increased, most frequently Chromosomes 5 and 15. Recurrent losses are seen on Chromosomes 10 and X. For aCGH (Panel II), the genomic map is depicted with chromosomes horizontally aligned centromere to telomere. The relative fluorescence intensities (tumor:normal) are indicated along the vertical axis. Individual BACs are plotted according to their physical map position versus relative fluorescence, with sample identities indicated by a unique symbol for each tumor. To simplify visualization, only BACs with relative intensities greater than 1.25 (gains) or less than 0.75 (losses) are shown. X Chromosome values were halved to account for sex-mismatched samples. Changes spanning the entire length of the chromosome are readily detected on Chromosomes 6, 8, 10, 15, 18, and X. None of the clones showing loss on Chromosome 11 spans the p53 locus. The original p53 background of the animal and the p53 LOH status of each tumor are also indicated in the legend.
###end p 173
###begin title 174
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
p53 LOH among the Majority of p53+/- Tumors
###end title 174
###begin p 175
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 231 244 231 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;&#916;Ct</sup>
###xml 327 341 319 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020022-Lu1">Lu et al. 2001</xref>
###xml 356 359 348 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 363 366 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 351 366 343 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub>;p53<sup>+/&#8722;</sup></italic>
###xml 393 396 385 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 424 427 416 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">121</sub>
###xml 431 434 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 419 434 411 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAP-T<sub>121</sub>;p53<sup>+/+</sup></italic>
###xml 456 459 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
Real-time PCR was performed in duplicate to determine the status of the wild-type p53 alleles in the mammary tumors or tissues as indicated. Analysis of standard samples indicates that copy numbers of 2, 1, and 0 are indicated by 2-DeltaDeltaCt values of greater than or equal to 0.7, 0.2-0.7, and less than 0.2, respectively (Lu et al. 2001). Of ten WAP-T121;p53+/- tumors, eight show LOH of p53 gene, while all three WAP-T121;p53+/+ tumors retained both p53 alleles. Abbreviation: Tg, transgenic
###end p 175
###begin p 176
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aTumor samples were derived from line 3 animals, except tumor 1, which was derived from a line 4 animal
###end p 176
###begin p 177
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 12 13 4 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 25 26 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 28 31 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 43 44 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 46 56 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 67 70 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 64 70 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/+</sup></italic>
###xml 83 86 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 93 96 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 90 96 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/+</sup></italic>
###xml 106 107 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 109 119 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 125 126 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
bDeltaDeltaCt = [sample Ct (p53) - sample Ct (beta-actin) ] - [ p53+/+ control Ct (p53) - p53+/+ control Ct (beta-actin) ]. Ct = the number of cycles required to reach a threshold value, which is set within the exponential phase of the logarithmic scale amplification plot
###end p 177
###begin p 178
###xml 0 22 0 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflicts of interest.</bold>
Conflicts of interest. The authors have declared that no conflicts of interest exist.
###end p 178
###begin p 179
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. KS, HW, and TVD conceived and designed the experiments. KS, HW, and LL performed the experiments. KS, HW, RDC, and TVD analyzed the data. DP and DA contributed reagents/materials/analysis tools. KS and TVD wrote the paper.
###end p 179
###begin p 180
Academic Editor: Chris Marshall, Institute for Cancer Research
###end p 180
###begin p 181
currencyCurrent address: Phenomix Corporation, La Jolla, California, United States of America
###end p 181

